Yu Jung Kim
Overview
Explore the profile of Yu Jung Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
258
Citations
3602
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Choi J, Park W, Kang M, Seo J, Jung E, et al.
Cancer Res Treat
. 2025 Mar;
PMID: 40083083
Purpose: Older cancer patients face unique challenges due to age-related physiological changes, increasing their vulnerability to treatment-related toxicities. Geriatric assessment (GA) is a validated tool for optimizing care, yet there...
2.
Spira A, Paz-Ares L, Han J, Shih J, Mascaux C, Roy U, et al.
J Thorac Oncol
. 2025 Jan;
PMID: 39864547
Introduction: Amivantamab, an EGFR-MET bispecific antibody, is approved for multiple indications in EGFR-mutated advanced NSCLC as monotherapy or combined with other agents. Intravenous amivantamab is associated with a 67% infusion-related...
3.
Kim J, Na H, Lee S, Kim J, Suh K, Kim S, et al.
Sci Rep
. 2025 Jan;
15(1):2171.
PMID: 39820489
Next-generation sequencing (NGS) cancer profiling has gained traction in routine clinical practice in South Korea. Here, we evaluated the use of NGS testing and genomically-matched therapies for patients with advanced...
4.
Park J, Choi J, Kim Y, Kim J
J Clin Neurol
. 2025 Jan;
21(1):89-91.
PMID: 39778574
No abstract available.
5.
Kim H, Jung E, Kwon J, Kim Y, Koh S, Lee M, et al.
Cancer Res Treat
. 2024 Dec;
PMID: 39638249
Purpose: Identifying the palliative care needs of patients with advanced cancer is important for maintaining quality of life and timely transition to palliative care. We aimed to validate the Korean...
6.
Yun J, Jung J, Keam B, Lee N, Kang J, Kim Y, et al.
Sci Rep
. 2024 Nov;
14(1):29098.
PMID: 39582048
Individuals diagnosed with advanced cancer often experience stress and depression, factors linked to worse survival. Curability belief-defined as the hope and expectation of cure through treatment, based on affective forecasting-may...
7.
Kim M, Kim Y, Suh K, Kim S, Kim J, Jeong J, et al.
Cancer
. 2024 Oct;
131(1):e35609.
PMID: 39422602
Background: In this single-arm, multicenter, phase 2 trial, the authors evaluated the efficacy and safety of avelumab plus gemcitabine in patients with leiomyosarcoma (LMS) who failed on first-line chemotherapy. Methods:...
8.
Lee J, Lee J, Park W, Seo J, Kang M, Jung E, et al.
Cancer Res Treat
. 2024 Sep;
PMID: 39300927
Purpose: Thrombosis and bleeding significantly affect morbidity and mortality in myeloproliferative neoplasms (MPNs). The efficacy and safety of direct oral anticoagulants (DOACs) in MPN patients remain uncertain. Materials And Methods:...
9.
Jung E, Hiratsuka Y, Suh S, Yoon S, Kang B, Lee S, et al.
Palliat Med Rep
. 2024 Sep;
5(1):365-372.
PMID: 39281186
Background: Timely palliative transition in patients with advanced cancer is essential for their improved quality of life and overall survival (OS). Most prognostic models have been developed focusing on weeks'...
10.
Hong M, Choi Y, Ahn H, Lim S, Keam B, Kim D, et al.
JAMA Oncol
. 2024 Aug;
10(10):1342-1351.
PMID: 39145962
Importance: EGFR-variant non-small cell lung cancer (NSCLC) is associated with a high rate of central nervous system (CNS) metastases, even with treatment with first-generation or second-generation epidermal growth factor receptor...